Skip to main content

Table 1 Baseline characteristics of mildly depressed women with type 2 diabetes who completed the trial

From: Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial

  Controls (n = 6) Paroxetine (n = 7)
  Mean SD Mean SD
Age (years) 62.3 11.5 61.1 8.6
Body mass index (kg/m2) 30.1 6.3 31.6 3.0
Metabolic parameters     
Fasting blood glucose (mmol/l) 8.4 1.3 8.9 2.8
HbA1c (%) 6.9 0.4 7.5 0.8
S-cholesterol (mmol/l) 5.5 1.4 5.8 1.0
HDL cholesterol (mmol/l) 1.6 0.4 1.4 0.2
LDL cholesterol (mmol/l) 3.0 1.2 3.7 0.9
S-triglycerides (mmol/l) 2.1 1.1 1.5 0.7
Free fatty acids (mmol/l) 0.9 0.4 1.0 0.2
Sex hormone binding globulin (nmol/l) 74.2 34.3 38.9 19.5
S-leptin (ng/ml) 32.2 14.9 22.9 15.2
S-cortisol (nmol/l) 460.2 130.0 550.7 120.7
Energy expenditure (kcal/d) 1516.7 167.7 1658.6 246.5
Mental status     
Hamilton's Anxiety Scale 9.3 3.7 13.7 4.2
Montgomery-Åsberg's Depression Rating Scale 6.4 4.0 7.4 2.9
Beck's Depression Inventory 13.0 9.2 13.7 7.4
RAND-36 436.8 182.0 455.6 142.7